CODEXIS, INC. cotiza a 1.32 USD y tiene una capitalización bursátil de $145M. En los últimos 12 meses ha facturado $78M con un margen de flujo de caja libre del -33.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and …
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | $-0.13 | — | $-0.10 |
| Estimado | $-0.09 | $-0.12 | $-0.12 | $-0.10 |
| Sorpresa | — | -8.3% | — | +0.0% |
| Métrica | CDXS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 86.7% | 57.0% | +29.7% |
| Operating Margin | -59.3% | -38.6% | -20.7% |
| Net Margin | -62.5% | -33.6% | -28.9% |
| FCF Margin | -33.9% | -13.9% | -20.0% |
| ROE | -87.0% | -40.4% | -46.6% |
| ROA | -29.8% | -32.0% | +2.3% |
| Current Ratio | 3.82 | 2.84 | +0.98 |
| Debt / Equity | 0.79 | 0.28 | +0.51 |